Advancing Diagnosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Insights from the LITMUS Multicentre Study
The LITMUS study evaluates non-invasive biomarkers for diagnosing metabolic dysfunction-associated steatotic liver disease, highlighting proteomic panels' promise in detecting at-risk steatohepatitis and fibrosis stages, potentially replacing biopsy.